{"pmid":32470153,"title":"Characteristics of inflammatory factors and lymphocyte subsets in patients with severe COVID-19.","text":["Characteristics of inflammatory factors and lymphocyte subsets in patients with severe COVID-19.","OBJECTIVE: To investigate the inflammatory factors and lymphocyte subsets which play an important role in the course of severe COVID-19. METHODS: A total of 27 patients with severe COVID-19 who were admitted to Tongji Hospital in Wuhan from 1 to 21 February 2020 were recruited to the study. The characteristics of interleukin (IL)-1beta, IL-2 receptor (IL-2R), IL-6, IL-8, IL-10, tumor necrosis factor (TNF)-alpha, C-reactive protein (CRP), serum ferritin and procalcitonin (PCT), and lymphocyte subsets of these patients were retrospectively compared before and after treatment. RESULTS: Before treatment, there was no significant difference in most inflammatory factors (IL-1beta, IL-2R, IL-6, IL-8, IL-10, CRP and serum ferritin) between male and female patients. Levels of IL-2R, IL-6, TNF-alpha and CRP decreased significantly after treatment, followed by IL-8, IL-10 and PCT. Serum Ferritin was increased in all patients before treatment, but did not decrease significantly after treatment. IL-1beta was normal in most patients before treatment. Lymphopenia was common among these patients with severe COVID-19. Analysis of lymphocyte subsets showed that CD4(+) and particularly CD8(+) T lymphocytes increased significantly after treatment. However, B lymphocytes and natural killer cells showed no significant changes after treatment. CONCLUSIONS: A pro-inflammatory response and decreased level of T lymphocytes were associated with severe COVID-19. This article is protected by copyright. All rights reserved.","J Med Virol","Ni, Ming","Tian, Fang-Bing","Xiang, Dan-Dan","Yu, Bing","32470153"],"abstract":["OBJECTIVE: To investigate the inflammatory factors and lymphocyte subsets which play an important role in the course of severe COVID-19. METHODS: A total of 27 patients with severe COVID-19 who were admitted to Tongji Hospital in Wuhan from 1 to 21 February 2020 were recruited to the study. The characteristics of interleukin (IL)-1beta, IL-2 receptor (IL-2R), IL-6, IL-8, IL-10, tumor necrosis factor (TNF)-alpha, C-reactive protein (CRP), serum ferritin and procalcitonin (PCT), and lymphocyte subsets of these patients were retrospectively compared before and after treatment. RESULTS: Before treatment, there was no significant difference in most inflammatory factors (IL-1beta, IL-2R, IL-6, IL-8, IL-10, CRP and serum ferritin) between male and female patients. Levels of IL-2R, IL-6, TNF-alpha and CRP decreased significantly after treatment, followed by IL-8, IL-10 and PCT. Serum Ferritin was increased in all patients before treatment, but did not decrease significantly after treatment. IL-1beta was normal in most patients before treatment. Lymphopenia was common among these patients with severe COVID-19. Analysis of lymphocyte subsets showed that CD4(+) and particularly CD8(+) T lymphocytes increased significantly after treatment. However, B lymphocytes and natural killer cells showed no significant changes after treatment. CONCLUSIONS: A pro-inflammatory response and decreased level of T lymphocytes were associated with severe COVID-19. This article is protected by copyright. All rights reserved."],"journal":"J Med Virol","authors":["Ni, Ming","Tian, Fang-Bing","Xiang, Dan-Dan","Yu, Bing"],"date":"2020-05-30T11:00:00Z","year":2020,"_id":"32470153","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1002/jmv.26070","keywords":["covid-19","lymphopenia","pro-inflammatory","severe pneumonia"],"locations":["Wuhan"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Treatment","Diagnosis"],"weight":1,"_version_":1668167110047563776,"score":9.490897,"similar":[{"pmid":32365221,"title":"Using IL-2R/lymphocyte for predicting the clinical progression of patients with COVID-19.","text":["Using IL-2R/lymphocyte for predicting the clinical progression of patients with COVID-19.","BACKGROUND: Effective laboratory markers for estimation of disease severity and predicting the clinical progression of coronavirus disease-2019 (COVID-19) is urgent needed. METHODS: The laboratory tests including blood routine, cytokine profiles and infection markers were collected from 389 confirmed COVID-19 patients. RESULTS: The included patients were classified into mild (n=168), severe (n=169) and critical groups (n=52). The leukocytes, neutrophils, infection biomarkers (such as CRP, PCT and ferritin) and the concentrations of cytokines (IL-2R, IL-6, IL-8, IL-10 and TNF-alpha) were significantly increased while lymphocytes were significantly decreased with increased severity of illness. The amounts of IL-2R was positively correlated with the other cytokines and negatively correlated with lymphocyte number. The ratio of IL-2R to lymphocytes was found remarkably increased in severe and critical patients. IL-2R/lymphocyte was superior compared with other markers for the identification of COVID-19 with critical illness not only from mild but also from severe illness. Moreover, the cytokine profiles and IL-2R/lymphocyte were significantly decreased in recovered patients but further increased in disease deteriorated patients, which might be correlated with the outcome of COVID-19. CONCLUSIONS: Lymphopenia and increased levels of cytokines were closely associated with the disease severity. IL-2R/lymphocyte was a prominent biomarker for early identification of severe COVID-19 and predicting the clinical progression of the disease.","Clin Exp Immunol","Hou, Hongyan","Zhang, Bo","Huang, Hui","Luo, Ying","Wu, Shiji","Tang, Guoxing","Liu, Weiyong","Mao, Lie","Mao, Liyan","Wang, Feng","Sun, Ziyong","32365221"],"abstract":["BACKGROUND: Effective laboratory markers for estimation of disease severity and predicting the clinical progression of coronavirus disease-2019 (COVID-19) is urgent needed. METHODS: The laboratory tests including blood routine, cytokine profiles and infection markers were collected from 389 confirmed COVID-19 patients. RESULTS: The included patients were classified into mild (n=168), severe (n=169) and critical groups (n=52). The leukocytes, neutrophils, infection biomarkers (such as CRP, PCT and ferritin) and the concentrations of cytokines (IL-2R, IL-6, IL-8, IL-10 and TNF-alpha) were significantly increased while lymphocytes were significantly decreased with increased severity of illness. The amounts of IL-2R was positively correlated with the other cytokines and negatively correlated with lymphocyte number. The ratio of IL-2R to lymphocytes was found remarkably increased in severe and critical patients. IL-2R/lymphocyte was superior compared with other markers for the identification of COVID-19 with critical illness not only from mild but also from severe illness. Moreover, the cytokine profiles and IL-2R/lymphocyte were significantly decreased in recovered patients but further increased in disease deteriorated patients, which might be correlated with the outcome of COVID-19. CONCLUSIONS: Lymphopenia and increased levels of cytokines were closely associated with the disease severity. IL-2R/lymphocyte was a prominent biomarker for early identification of severe COVID-19 and predicting the clinical progression of the disease."],"journal":"Clin Exp Immunol","authors":["Hou, Hongyan","Zhang, Bo","Huang, Hui","Luo, Ying","Wu, Shiji","Tang, Guoxing","Liu, Weiyong","Mao, Lie","Mao, Liyan","Wang, Feng","Sun, Ziyong"],"date":"2020-05-05T11:00:00Z","year":2020,"_id":"32365221","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.1111/cei.13450","keywords":["covid-19","il-2r/lymphocyte ratio","sars-cov-2","clinical progression","cytokine"],"locations":["Lymphopenia"],"topics":["Treatment","Diagnosis"],"weight":1,"_version_":1666138496044105728,"score":601.68915},{"pmid":32026671,"title":"[Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia].","text":["[Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia].","Objective: To analyze the clinical characteristics of 2019 novel coronavirus (2019-nCoV) pneumonia and to investigate the correlation between serum inflammatory cytokines and severity of the disease. Methods: 29 patients with 2019-ncov admitted to the isolation ward of Tongji hospital affiliated to Tongji medical college of Huazhong University of Science and Technology in January 2020 were selected as the study subjects. Clinical data were collected and the general information, clinical symptoms, blood test and CT imaging characteristics were analyzed. According to the relevant diagnostic criteria, the patients were divided into three groups: mild (15 cases), severe (9 cases) and critical (5 cases). The expression levels of inflammatory cytokines and other markers in the serum of each group were detected, and the changes of these indicators of the three groups were compared and analyzed, as well as their relationship with the clinical classification of the disease. Results: (1) The main symptoms of 2019-nCoV pneumonia was fever (28/29) with or without respiratory and other systemic symptoms. Two patients died with underlying disease and co-bacterial infection, respectively. (2) The blood test of the patients showed normal or decreased white blood cell count (23/29), decreased lymphocyte count (20/29), increased hypersensitive C reactive protein (hs-CRP) (27/29), and normal procalcitonin. In most patients,serum lactate dehydrogenase (LDH) was significantly increased (20/29), while albumin was decreased(15/29). Alanine aminotransferase (ALT), aspartate aminotransferase (AST), total bilirubin (Tbil), serum creatinine (Scr) and other items showed no significant changes. (3) CT findings of typical cases were single or multiple patchy ground glass shadows accompanied by septal thickening. When the disease progresses, the lesion increases and the scope expands, and the ground glass shadow coexists with the solid shadow or the stripe shadow. (4) There were statistically significant differences in the expression levels of interleukin-2 receptor (IL-2R) and IL-6 in the serum of the three groups (P<0.05), among which the critical group was higher than the severe group and the severe group was higher than the mildgroup. However, there were no statistically significant differences in serum levels of tumor necrosis factor-alpha (TNF-alpha), IL-1, IL-8, IL-10, hs-CRP, lymphocyte count and LDH among the three groups (P>0.05). Conclusion: The clinical characteristics of 2019-nCoV pneumonia are similar to those of common viral pneumonia. High resolution CT is of great value in the differential diagnosis of this disease. The increased expression of IL-2R and IL-6 in serum is expected to predict the severity of the 2019-nCoV pneumonia and the prognosis of patients.","Zhonghua Jie He He Hu Xi Za Zhi","Chen, L","Liu, H G","Liu, W","Liu, J","Liu, K","Shang, J","Deng, Y","Wei, S","32026671"],"abstract":["Objective: To analyze the clinical characteristics of 2019 novel coronavirus (2019-nCoV) pneumonia and to investigate the correlation between serum inflammatory cytokines and severity of the disease. Methods: 29 patients with 2019-ncov admitted to the isolation ward of Tongji hospital affiliated to Tongji medical college of Huazhong University of Science and Technology in January 2020 were selected as the study subjects. Clinical data were collected and the general information, clinical symptoms, blood test and CT imaging characteristics were analyzed. According to the relevant diagnostic criteria, the patients were divided into three groups: mild (15 cases), severe (9 cases) and critical (5 cases). The expression levels of inflammatory cytokines and other markers in the serum of each group were detected, and the changes of these indicators of the three groups were compared and analyzed, as well as their relationship with the clinical classification of the disease. Results: (1) The main symptoms of 2019-nCoV pneumonia was fever (28/29) with or without respiratory and other systemic symptoms. Two patients died with underlying disease and co-bacterial infection, respectively. (2) The blood test of the patients showed normal or decreased white blood cell count (23/29), decreased lymphocyte count (20/29), increased hypersensitive C reactive protein (hs-CRP) (27/29), and normal procalcitonin. In most patients,serum lactate dehydrogenase (LDH) was significantly increased (20/29), while albumin was decreased(15/29). Alanine aminotransferase (ALT), aspartate aminotransferase (AST), total bilirubin (Tbil), serum creatinine (Scr) and other items showed no significant changes. (3) CT findings of typical cases were single or multiple patchy ground glass shadows accompanied by septal thickening. When the disease progresses, the lesion increases and the scope expands, and the ground glass shadow coexists with the solid shadow or the stripe shadow. (4) There were statistically significant differences in the expression levels of interleukin-2 receptor (IL-2R) and IL-6 in the serum of the three groups (P<0.05), among which the critical group was higher than the severe group and the severe group was higher than the mildgroup. However, there were no statistically significant differences in serum levels of tumor necrosis factor-alpha (TNF-alpha), IL-1, IL-8, IL-10, hs-CRP, lymphocyte count and LDH among the three groups (P>0.05). Conclusion: The clinical characteristics of 2019-nCoV pneumonia are similar to those of common viral pneumonia. High resolution CT is of great value in the differential diagnosis of this disease. The increased expression of IL-2R and IL-6 in serum is expected to predict the severity of the 2019-nCoV pneumonia and the prognosis of patients."],"journal":"Zhonghua Jie He He Hu Xi Za Zhi","authors":["Chen, L","Liu, H G","Liu, W","Liu, J","Liu, K","Shang, J","Deng, Y","Wei, S"],"date":"2020-02-07T11:00:00Z","year":2020,"_id":"32026671","source":"PubMed","week":"20206|Feb 03 - Feb 09","doi":"10.3760/cma.j.issn.1001-0939.2020.0005","keywords":["2019 novel coronavirus pneumonia","clinical features","disease severity","inflammatory cytokines"],"locations":["Tongji","Tongji"],"e_drugs":["Creatinine","Bilirubin"],"topics":["Mechanism","Diagnosis"],"weight":1,"_version_":1666138490890354688,"score":522.2777},{"pmid":32475230,"title":"Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors.","text":["Profiling serum cytokines in COVID-19 patients reveals IL-6 and IL-10 are disease severity predictors.","Since the outbreak of coronavirus disease 2019 (COVID-19) in Wuhan, China, it has rapidly spread across many other countries. While the majority of patients were considered mild, critically ill patients involving respiratory failure and multiple organ dysfunction syndrome are not uncommon, which could result death. We hypothesized that cytokine storm is associated with severe outcome. We enrolled 102 COVID-19 patients who were admitted to Renmin Hospital (Wuhan, China). All patients were classified into moderate, severe and critical groups according to their symptoms. 45 control samples of healthy volunteers were also included. Inflammatory cytokines and C-Reactive Protein (CRP) profiles of serum samples were analyzed by specific immunoassays. Results showed that COVID-19 patients have higher serum level of cytokines (TNF-alpha, IFN-gamma, IL-2, IL-4, IL-6 and IL-10) and CRP than control individuals. Within COVID-19 patients, serum IL-6 and IL-10 levels are significantly higher in critical group (n = 17) than in moderate (n = 42) and severe (n = 43) group. The levels of IL-10 is positively correlated with CRP amount (r = 0.41, P < 0.01). Using univariate logistic regression analysis, IL-6 and IL-10 are found to be predictive of disease severity and receiver operating curve analysis could further confirm this result (AUC = 0.841, 0.822 respectively). Our result indicated higher levels of cytokine storm is associated with more severe disease development. Among them, IL-6 and IL-10 can be used as predictors for fast diagnosis of patients with higher risk of disease deterioration. Given the high levels of cytokines induced by SARS-CoV-2, treatment to reduce inflammation-related lung damage is critical.","Emerg Microbes Infect","Han, Huan","Ma, Qingfeng","Li, Cong","Liu, Rui","Zhao, Li","Wang, Wei","Zhang, Pingan","Liu, Xinghui","Gao, Guosheng","Liu, Fang","Jiang, Yingan","Cheng, Xiaoming","Zhu, Chengliang","Xia, Yuchen","32475230"],"abstract":["Since the outbreak of coronavirus disease 2019 (COVID-19) in Wuhan, China, it has rapidly spread across many other countries. While the majority of patients were considered mild, critically ill patients involving respiratory failure and multiple organ dysfunction syndrome are not uncommon, which could result death. We hypothesized that cytokine storm is associated with severe outcome. We enrolled 102 COVID-19 patients who were admitted to Renmin Hospital (Wuhan, China). All patients were classified into moderate, severe and critical groups according to their symptoms. 45 control samples of healthy volunteers were also included. Inflammatory cytokines and C-Reactive Protein (CRP) profiles of serum samples were analyzed by specific immunoassays. Results showed that COVID-19 patients have higher serum level of cytokines (TNF-alpha, IFN-gamma, IL-2, IL-4, IL-6 and IL-10) and CRP than control individuals. Within COVID-19 patients, serum IL-6 and IL-10 levels are significantly higher in critical group (n = 17) than in moderate (n = 42) and severe (n = 43) group. The levels of IL-10 is positively correlated with CRP amount (r = 0.41, P < 0.01). Using univariate logistic regression analysis, IL-6 and IL-10 are found to be predictive of disease severity and receiver operating curve analysis could further confirm this result (AUC = 0.841, 0.822 respectively). Our result indicated higher levels of cytokine storm is associated with more severe disease development. Among them, IL-6 and IL-10 can be used as predictors for fast diagnosis of patients with higher risk of disease deterioration. Given the high levels of cytokines induced by SARS-CoV-2, treatment to reduce inflammation-related lung damage is critical."],"journal":"Emerg Microbes Infect","authors":["Han, Huan","Ma, Qingfeng","Li, Cong","Liu, Rui","Zhao, Li","Wang, Wei","Zhang, Pingan","Liu, Xinghui","Gao, Guosheng","Liu, Fang","Jiang, Yingan","Cheng, Xiaoming","Zhu, Chengliang","Xia, Yuchen"],"date":"2020-06-02T11:00:00Z","year":2020,"_id":"32475230","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1080/22221751.2020.1770129","keywords":["covid-19","interleukin 10","interleukin 6","sars-cov-2","cytokine storm","inflammatory cytokines"],"locations":["Wuhan","China","Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Treatment","Diagnosis"],"weight":1,"_version_":1668437835062968320,"score":402.52188},{"pmid":32391668,"title":"[Dynamic inflammatory response in a critically ill COVID-19 patient treated with corticosteroids].","text":["[Dynamic inflammatory response in a critically ill COVID-19 patient treated with corticosteroids].","OBJECTIVE: To investigate the effect of corticosteroids therapy on the inflammatory response in a critically ill coronavirus disease 2019 (COVID-19) patient. METHODS: A 55-year old female patient with critical ill COVID-19 was admitted in Taizhou Hospital on January 19, 2020. The patient was treated with methylprednisolone 80 mg on the 2nd day after admission. Thereafter, the dose was adjusted in a timely manner and the therapy lasted for 13 days. The peripheral lymphocyte subsets (CD3(+)T, CD4(+) T, CD8(+) T, NK cells, B cells), as well as serum levels of lymphocyte factors (IL-2, IL-4, IL-6, IL-10, TNF-alpha, IFN-gamma) were dynamically monitored. RESULTS: On D1 of admission, the numbers of peripheral blood CD3(+) T, CD4(+) T, CD8(+) T, and NK cells were significantly lower than the normal range. With the improvement of the disease, the numbers of CD3(+) T, CD8(+) T and CD4 (+) T cells gradually recovered and showed a linear growth trend (linear fitting equation: Y=18.59X+109.4, P<0.05). On D2 of admission, the patient's IL-6 and IL-10 levels were significantly higher than normal values, IFN-gamma was at a normal high value, and then rapidly decreased; IL-2, IL-4, and TNF-alpha were all in the normal range. On the D6 and D7, the IL-6 and IL-10 decreased to the normal range for the first time. On the D18, the sputum virus nucleic acid test was negative for the first time, and the fecal virus nucleic acid test was still positive; on the D20 the sputum and fecal virus nucleic acid test were both negative. On D34, the patient recovered and was discharged. At the discharge the muscle strength score of the patient was 44 and the daily life ability evaluation was 90. CONCLUSIONS: In the absence of effective antiviral drugs, early use of appropriate doses of corticosteroids in critically ill patient with COVID-19 can quickly alleviate inflammatory response and improve clinical symptoms, however, it may reduce the number of T cells, and to adjust the dose in time is necessary.","Zhejiang Da Xue Xue Bao Yi Xue Ban","Zhagn, Sheng","Li, Danping","Chen, Huazhong","Zheng, Dan","Zhou, Yiping","Chen, Baoguo","Shi, Weiwu","Lin, Ronghai","32391668"],"abstract":["OBJECTIVE: To investigate the effect of corticosteroids therapy on the inflammatory response in a critically ill coronavirus disease 2019 (COVID-19) patient. METHODS: A 55-year old female patient with critical ill COVID-19 was admitted in Taizhou Hospital on January 19, 2020. The patient was treated with methylprednisolone 80 mg on the 2nd day after admission. Thereafter, the dose was adjusted in a timely manner and the therapy lasted for 13 days. The peripheral lymphocyte subsets (CD3(+)T, CD4(+) T, CD8(+) T, NK cells, B cells), as well as serum levels of lymphocyte factors (IL-2, IL-4, IL-6, IL-10, TNF-alpha, IFN-gamma) were dynamically monitored. RESULTS: On D1 of admission, the numbers of peripheral blood CD3(+) T, CD4(+) T, CD8(+) T, and NK cells were significantly lower than the normal range. With the improvement of the disease, the numbers of CD3(+) T, CD8(+) T and CD4 (+) T cells gradually recovered and showed a linear growth trend (linear fitting equation: Y=18.59X+109.4, P<0.05). On D2 of admission, the patient's IL-6 and IL-10 levels were significantly higher than normal values, IFN-gamma was at a normal high value, and then rapidly decreased; IL-2, IL-4, and TNF-alpha were all in the normal range. On the D6 and D7, the IL-6 and IL-10 decreased to the normal range for the first time. On the D18, the sputum virus nucleic acid test was negative for the first time, and the fecal virus nucleic acid test was still positive; on the D20 the sputum and fecal virus nucleic acid test were both negative. On D34, the patient recovered and was discharged. At the discharge the muscle strength score of the patient was 44 and the daily life ability evaluation was 90. CONCLUSIONS: In the absence of effective antiviral drugs, early use of appropriate doses of corticosteroids in critically ill patient with COVID-19 can quickly alleviate inflammatory response and improve clinical symptoms, however, it may reduce the number of T cells, and to adjust the dose in time is necessary."],"journal":"Zhejiang Da Xue Xue Bao Yi Xue Ban","authors":["Zhagn, Sheng","Li, Danping","Chen, Huazhong","Zheng, Dan","Zhou, Yiping","Chen, Baoguo","Shi, Weiwu","Lin, Ronghai"],"date":"2020-05-12T11:00:00Z","year":2020,"_id":"32391668","source":"PubMed","week":"202020|May 11 - May 17","e_drugs":["Methylprednisolone"],"topics":["Case Report"],"weight":1,"_version_":1666528580184571904,"score":393.58554},{"pmid":32452979,"title":"Pediatric Crohn's Disease and Multisystem Inflammatory Syndrome in Children (MIS-C) and COVID-19 Treated with Infliximab.","text":["Pediatric Crohn's Disease and Multisystem Inflammatory Syndrome in Children (MIS-C) and COVID-19 Treated with Infliximab.","Coronavirus disease 2019 (COVID-19) may lead to a severe inflammatory response referred to as a cytokine storm. We describe a case of severe COVID-19 infection in a recently diagnosed pediatric Crohn's disease patient successfully treated with Tumor Necrosis Factor-alpha (TNF-alpha) blockade. The patient presented with five days of fever, an erythematous maculopapular facial rash, and abdominal pain without respiratory symptoms. SARS-CoV-2 PCR was positive. Despite inpatient treatment for COVID-19 and a perianal abscess, the patient acutely decompensated, with worsening fever, tachycardia, fluid-refractory hypotension, elevation of liver enzymes, and transformation of the rash into purpura extending from the face to the trunk, upper and lower extremities, including the palmar and plantar surfaces of the hands and feet. Cytokine profile revealed rising levels of interleukin (IL)-6, IL-8, and TNF-alpha, higher than those described in either inflammatory bowel disease (IBD) or severe COVID-19 alone. The patient was treated with infliximab for TNF-alpha blockade to address both moderately to severely active Crohn's disease and multisystem inflammatory syndrome in children (MIS-C) temporally related to COVID-19. Within hours of infliximab treatment, fever, tachycardia and hypotension resolved. Cytokine profile improved with normalization of TNF-alpha, a decrease in IL-6, and IL-8 concentrations. This case supports a role for blockade of TNF-alpha in the treatment of COVID-19 inflammatory cascade. The role of anti-TNF agents in patients with MIS-C temporally related to COVID-19 requires further investigation.","J Pediatr Gastroenterol Nutr","Dolinger, Michael T","Person, Hannibal","Smith, Rachel","Jarchin, Lauren","Pittman, Nanci","Dubinsky, Marla C","Lai, Joanne","32452979"],"abstract":["Coronavirus disease 2019 (COVID-19) may lead to a severe inflammatory response referred to as a cytokine storm. We describe a case of severe COVID-19 infection in a recently diagnosed pediatric Crohn's disease patient successfully treated with Tumor Necrosis Factor-alpha (TNF-alpha) blockade. The patient presented with five days of fever, an erythematous maculopapular facial rash, and abdominal pain without respiratory symptoms. SARS-CoV-2 PCR was positive. Despite inpatient treatment for COVID-19 and a perianal abscess, the patient acutely decompensated, with worsening fever, tachycardia, fluid-refractory hypotension, elevation of liver enzymes, and transformation of the rash into purpura extending from the face to the trunk, upper and lower extremities, including the palmar and plantar surfaces of the hands and feet. Cytokine profile revealed rising levels of interleukin (IL)-6, IL-8, and TNF-alpha, higher than those described in either inflammatory bowel disease (IBD) or severe COVID-19 alone. The patient was treated with infliximab for TNF-alpha blockade to address both moderately to severely active Crohn's disease and multisystem inflammatory syndrome in children (MIS-C) temporally related to COVID-19. Within hours of infliximab treatment, fever, tachycardia and hypotension resolved. Cytokine profile improved with normalization of TNF-alpha, a decrease in IL-6, and IL-8 concentrations. This case supports a role for blockade of TNF-alpha in the treatment of COVID-19 inflammatory cascade. The role of anti-TNF agents in patients with MIS-C temporally related to COVID-19 requires further investigation."],"journal":"J Pediatr Gastroenterol Nutr","authors":["Dolinger, Michael T","Person, Hannibal","Smith, Rachel","Jarchin, Lauren","Pittman, Nanci","Dubinsky, Marla C","Lai, Joanne"],"date":"2020-05-27T11:00:00Z","year":2020,"_id":"32452979","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1097/MPG.0000000000002809","locations":["Cytokine","Cytokine","Children"],"e_drugs":["Infliximab"],"topics":["Treatment","Mechanism"],"weight":1,"_version_":1667983494585778176,"score":359.8661}]}